SPECTROPHOTOMETRIC DETERMINATION OF DORIPENEM, ERTAPENEM IN BULK AND INJECTION FORMULATIONS BY F-C REAGENT
Abstract
Two simple and cost effective spectrophotometric methods were described for the determination of Doripenem and Ertapenem in pure form and in pharmaceutical formulations. The method is based on the formation of blue colored chromogen when the drug reacts with Folin-Ciocalteu (F-C) reagent in alkaline medium. The colored species has an absorption maximum at 725 nm for Doripenem (Method A); 848 nm for Ertapenem (Method B) and obeys beer’s law in the concentration range 0.02-0.1 mg/mL for both Doripenem and Ertapenem. The apparent molar absorptivities were 1.26×10-5, 7.86×10-6 and sandell’s sensitivity was 6×10-4 respectively for Doripenem and Ertapenem. The slopes were 0.3371 ± 0.01245, 0.2611 ± 0.004327 and intercept of the equation of the regression line are 0.02857 ± 0.01885, -0.008095 ± 0.006550 for Doripenem and Ertapenem respectively. The optimum experimental parameters for the reaction have been studied and the validity of the described procedure was assessed. Statistical analysis of the results has been carried out revealing high accuracy and good precision. The proposed method was successfully applied for the determination of Doripenem and Ertapenem in pharmaceutical formulations.
Keywords:
Doripenem, Ertapenem, F-C reagent, SpectrophotometryDOI
https://doi.org/10.25004/IJPSDR.2013.050410References
2. The United States Pharmacopeia (USP 30), National Formulary (NF25), The United States Pharmacopeial Convention, Inc., Rockville 2007, pp. 2334-2336.
3. Musson DG, Birk KL, Kitchen CJ, Zhang J, Hsieh JYK, Fang W, Majumdar AK, Rogers JD. Assay methodology for the quantification of unbound ertapenem, a new carbapenem antibiotic, in human plasma. Journal of Chromatography B 2003; 783: 1.
4. Mundkowski RG, Peszynska JM, Burkhardt O, Welte T, Drewelow B. A new simple HPLC assay for the quantification of ertapenem in human plasma, lung tissues, and broncho-alveolar lavage fluid. Journal of Chromatography B 2006; 832: 231.
5. Koal T, Deters M, Resch K, Kaever V. Quantification of the carbapenem antibiotic ertapenem in human plasma by a validated liquid chromatography-mass spectrometry method. Clin. Chim. Acta 2006; 364: 239.
6. Soltani M, MacGowan AP, Lovering AM. Assay of ertapenem in human serum by high-performance liquid chromatography Int. J. Antimicrob. Agents 2006; 27: 165.
7. Zajac M, Cielecka-Piontek J, Jelinska A. Development and validation of UV spectrophotometric and RP-HPLC methods for determination of ertapenem during stability studies. Chem. Anal. 2006; 51: 761.
8. Hassan NY., Adbel-Moety EM, Elragery NA and Rezk MR. Selective determination of ertapenem in the presence of its degradation product. Spectrochim. Acta A: Mol. Biomol. Spectrosc, 2009; 72: 915-921.
9. Piontek JC, Jelinska A. The UV-derivative spectrophotometry for the determination of doripenem in the presence of its degradation products, Spectrochimica Acta Part A: Mol. Biomolecular Spectroscopy 2010; 77: 554-557.
Published

